Discover the latest strategic moves of Duquesne Family Office's $3.72B portfolio, including new stakes, increased investments ...

Perceive Pharma, a pharmaceutical company pioneering novel small molecule therapeutics in ophthalmology, today announced the closing of a $15M Series A funding round including Deerfield Management, ...

TD Cowen analyst Moshe Orenbuch maintained a Hold rating on Capital One Financial (COF – Research Report) today and set a price target of ...

The Saxo Quick Take is a short, distilled opinion on financial markets with references to key news and events. Macro data and headlines  ...

Let's look at five biotech and drug companies, AXSM, HALO, FOLD, BMRN and INSM, slated to release their fourth-quarter 2024 results this week.

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Stephen Mandel’s Lone Pine Capital disclosed in an SEC filing its holdings as of December 31, 2024. Lone Pine’s four new buys during the fourth ...

Renaissance Technologies took a new stake in Intel (NASDAQ:INTC), exited its position in Arm (NASDAQ:ARM), significantly upped its holdings in Nike (NYSE:NKE) and almost entirely sold out of Alphabet ...

In the GLP-1 weight loss market, it's largely been a two-horse race between Eli Lilly and Novo Nordisk (NYSE: NVO). The two ...

Nemluvio, which was also approved for prurigo nodularis, becomes Galderma’s first approved biologic in its dermatology ...